It has also been claimed that OLR did not affect IB in HT 29 colon cancer when administered at 400 and 800 M. Phosphorylation of inhibitor proteins, such as IB, is a common mechanism for activating NF-κB. This evidence concerns the gene NFKB1 and colonic neoplasm.